Sfoglia per AUTORE
BAROSI G
Collezione ASL Asti

  

Items : 4

Infection control in patients treated for chronic lymphocytic leukemia with ibrutinib or idelalisib: recommendations from Italian society of hematology. in Leukemia research / Leuk Res. 2019 Jun;81:88-94. doi: 10.1016/j.leukres.2019.04.016. Epub 2019 May 2.
2019
ASL Asti

Zinzani PL; Rambaldi A; Gaidano G; Girmenia C; Marchetti M; Pane F; Tura S; Barosi G;

Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet. in Leukemia / Leukemia. 2018 May;32(5):1057-1069. doi: 10.1038/s41375-018-0077-1. Epub 2018 Feb 27.
2018
ASL Asti

Barbui T; Tefferi A; Vannucchi AM; Passamonti F; Silver RT; Hoffman R; Verstovsek S; Mesa R; Kiladjian JJ; Hehlmann R; Reiter A; Cervantes F; Harrison C; Mc Mullin MF; Hasselbalch HC; Koschmieder S; Marchetti M; Bacigalupo A; Finazzi G; Kroeger N; Griesshammer M; Birgegard G; Barosi G;

Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations. in Leukemia / Leukemia. 2017 Apr;31(4):882-888. doi: 10.1038/leu.2016.283. Epub 2016 Oct 14.
2017
ASL Asti

Marchetti M; Barosi G; Cervantes F; Birgegård G; Griesshammer M; Harrison C; Hehlmann R; Kiladjian JJ; Kröger N; McMullin MF; Passamonti F; Vannucchi A; Barbui T;

2015
ASL Asti
AO Ordine Mauriziano
AOU Città della Salute di Torino

Tura S; Marchetti M; Rambaldi A; Vitolo U; Billio A; Arcaini L; Baldini L; Barosi G; Tarella C; Zinzani PL;